Detalhe da pesquisa
1.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Mult Scler
; 21(10): 1322-31, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25583832
2.
Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy.
Epilepsia
; 55(10): 1544-50, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25154625
3.
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease.
Clin Ther
; 42(6): 1034-1046, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482490
4.
Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Clin Ther
; 31(2): 328-35, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19302905
5.
Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
Clin Ther
; 30(12): 2263-71, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167586
6.
Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Clin Ther
; 29(4): 661-9, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17617289
7.
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Clin Ther
; 28(9): 1308-17, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17062304
8.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Ther Clin Risk Manag
; 11: 1-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25565851
9.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Postgrad Med
; 127(2): 218-22, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25560174
10.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Int J MS Care
; 17(6): 275-83, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26664333
11.
Dalfampridine in chronic sensorimotor deficits after ischemic stroke: A proof of concept study.
J Rehabil Med
; 47(10): 924-31, 2015 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26540083
12.
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Int J MS Care
; 17(3): 138-45, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26052259
13.
Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis.
Ann N Y Acad Sci
; 1329: 33-44, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25154911
14.
Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
Epilepsy Res
; 108(7): 1204-11, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24934774
15.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study.
J Clin Pharmacol
; 54(1): 53-60, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24150835
16.
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis.
Curr Med Res Opin
; 29(12): 1637-45, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23157466
17.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis.
Curr Med Res Opin
; 29(12): 1627-36, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23157467
18.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Neuropsychiatr Dis Treat
; 9: 365-70, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23662056
19.
Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets.
Degener Neurol Neuromuscul Dis
; 2: 53-64, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890878
20.
Effect of food on the single-dose pharmacokinetics and tolerability of dalfampridine extended-release tablets in healthy volunteers.
Am J Health Syst Pharm
; 68(22): 2148-54, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058101